{
  "id": 171107,
  "title": "Novo Not Discussing Further Pill Discounts, CEO Says",
  "url": "https://urgent.news/2026/08/05/novo-not-discussing-further-pill-discounts-ceo-says",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-05T09:08:08.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/videos/2026-08-05/novo-not-discussing-further-pill-discounts-ceo-says-video"
  },
  "original_language": "en",
  "account": null,
  "summary": "Novo Nordisk A/S Chief Executive Officer Mike Doustdar talks about the company's performance as its popular Wegovy weight-loss pill disappointed investors with sales that failed to live up to the hype. \"We are not right now discussing further discounts,\" Doustdar tells Bloomberg's Francine Lacqua. (Source: Bloomberg)",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}